Sassine Andy

Sassine Andy is listed in filings as Chief Financial Officer at Arcturus Therapeutics Holdings Inc.. This profile follows SEC Form 4 activity through Aug 20, 2025, including purchase activity and sale activity. Recent filings connect the profile to Arcturus Therapeutics Holdings Inc. (ARCT) and iCAD, Inc. (ICAD). The current snapshot covers public activity from Jun 14, 2024 to Aug 20, 2025. Reported amounts are shown as $20.5K to $216.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.